Tumor necrosis factor α antagonist therapies represent an increased risk of reactivation of tuberculosis. We report two cases of life-threatening disseminated tuberculosis in patients undergoing treatment with infliximab for Crohn's disease including one case of a patient with cerebral tuberculomas.We discuss the implication of tumor necrosis factor α in the genesis of tuberculosis infection and the features of tuberculosis under infliximab.Tuberculosis screening and eventually preventive chemotherapy should become the standard of care for individual undergoing tumor necrosis factor α antagonist therapies. © 2012 .
Tissot, C., Couraud, S., Meng, L., Girard, P., Avrillon, V., Gérinière, L., … Souquet, P. J. (2012). Life-threatening disseminated tuberculosis as a complication of treatment by infliximab for Crohn’s disease: Report of two cases, including cerebral tuberculomas and miliary tuberculosis. Journal of Crohn’s and Colitis, 6(9), 946–949. https://doi.org/10.1016/j.crohns.2012.02.018